Literature DB >> 1276533

Evidence concerning the involvement of 5-hydroxytryptamine in the locomotor activity produced by amphetamine or tranylcypromine plus L-DOPA.

A R Green, P H Kelly.   

Abstract

1 Pretreatment of rats with p-chlorophenylalanine (PCPA; 2 X 200 mg/kg) decreased the concentration of 5-hydroxytryptamine (5-HT) in the brain. It also decreased the locomotor activity produced by tranylcypromine plus L-DOPA administration 24 h after the second dose of PCPA. 2 Pretreatment with p-chloroamphetamine, which produced a similar decrease in brain 5-HT concentrations did not decrease the locomotor response to tranylcypromine and L-DOPA. 3 PCPA pretreatment decreased the rise in the concentration of DOPA and dopamine in the brain following tranylcypromine and L-DOPA, suggesting its effect on the dopamine-induced locomotor activity was the result of this drug diminishing dopamine formation in the brain, probably by inhibiting L-DOPA uptake. 4 The locomotor activity produced by tranylcypromine and L-DOPA was not decreased by pretreatment 6 h earlier with disulfiram (400 mg/kg). This argues against the locomotor activity being due to noradrenergic stimulation. 5 PCPA pretreatment did not alter amphetamine-induced stereotypy or the circling behaviour in unilateral nigro-striatal lesioned rats.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1276533      PMCID: PMC1667008          DOI: 10.1111/j.1476-5381.1976.tb07664.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  38 in total

1.  Stereotyped and circling behaviour induced by dopaminergic agonists after lesions of the midbrain raphe nuclei.

Authors:  B Costall; R J Naylor
Journal:  Eur J Pharmacol       Date:  1974-12       Impact factor: 4.432

2.  Action of two hypothalamic factors (TRH, MIF) and of angiotensin II on the behavioral effects of L-DOPA and 5-hydroxytryptophan in mice.

Authors:  J P Huidobro-Toro; A S De Carolis; V G Longo
Journal:  Pharmacol Biochem Behav       Date:  1974 Jan-Feb       Impact factor: 3.533

3.  Structural specificity for inhibition of [14C]-5-hydroxytryptamine uptake by cerebral slices.

Authors:  A Carlsson
Journal:  J Pharm Pharmacol       Date:  1970-10       Impact factor: 3.765

4.  DL-5-hydroxytryptophan-induced changes in central monoamine neurons after peripheral decarboxylase inhibition.

Authors:  K Fuxe; L L Butcher; J Engel
Journal:  J Pharm Pharmacol       Date:  1971-06       Impact factor: 3.765

5.  The role of brain dopamine in the hyperactivity syndrome produced by increased 5-hydroxytryptamine synthesis in rats.

Authors:  A R Green; D G Grahame-Smith
Journal:  Neuropharmacology       Date:  1974-11       Impact factor: 5.250

6.  On the mechanism of brain 5-hydroxytryptamine depletion by p-chloroamphetamine and related drugs and the specificity of their action.

Authors:  E Sanders-Bush; D A Gallager; F Sulser
Journal:  Adv Biochem Psychopharmacol       Date:  1974

7.  Central decarboxylation and uptake of L-DOPA.

Authors:  N E Andén; J Engel; A Rubenson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

8.  The effect of p-chloroamphetamine on motility in rats after inhibition of monoamine synthesis, storage, uptake and receptor interaction.

Authors:  J B Lassen
Journal:  Psychopharmacologia       Date:  1974-01-14

9.  Kinetics of serotonin accumulation into synaptosomes of rat brain--effects of amphetamine and chloroamphetamines.

Authors:  D T Wong; J S Horng; R W Fuller
Journal:  Biochem Pharmacol       Date:  1973-02-01       Impact factor: 5.858

10.  Apomorphine: modification of its hyperthermic effect in rabbits by p-chlorophenylalanine.

Authors:  R M Quock; A Horita
Journal:  Science       Date:  1974-02-08       Impact factor: 47.728

View more
  15 in total

1.  Human behavioural arousal induced by dopamine.

Authors:  D J Boullin; C B Adams; G H Du Boulay
Journal:  Br J Clin Pharmacol       Date:  1978-10       Impact factor: 4.335

2.  Further observations on the effect of repeated electroconvulsive shock on the behavioural responses of rats produced by increases in the functional activity of brain 5-hydroxytryptamine and dopamine.

Authors:  A R Green; D J Heal; D G Grahame-Smith
Journal:  Psychopharmacology (Berl)       Date:  1977-04-29       Impact factor: 4.530

3.  Neuroleptic drugs block both the hyperactivity and the increase in caudate nucleus cyclic AMP concentration produced by the administration of tranylcypromine and L-dopa to rats.

Authors:  D J Heal; A R Green; M R Bloomfield; D G Grahame-Smith
Journal:  Psychopharmacology (Berl)       Date:  1978-04-28       Impact factor: 4.530

4.  Evidence for dopamine deamination by both type A and type B monoamine oxidase in rat brain in vivo and for the degree of inhibition of enzyme necessary for increased functional activity of dopamine and 5-hydroxytryptamine.

Authors:  A R Green; B D Mitchell; A F Tordoff; M B Youdim
Journal:  Br J Pharmacol       Date:  1977-07       Impact factor: 8.739

5.  A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists.

Authors:  A R Green; J E Hall; A R Rees
Journal:  Br J Pharmacol       Date:  1981-07       Impact factor: 8.739

6.  Single and repeated administration of neuroleptic drugs to rats: effects on striatal dopamine-sensitive adenylate cyclase and locomotor activity produced by tranylcypromine and L-tryptophan or L-Dopa.

Authors:  D J Heal; A R Green; D J Boullin; D G Grahame-Smith
Journal:  Psychopharmacology (Berl)       Date:  1976-09-29       Impact factor: 4.530

Review 7.  Pharmacological models of ADHD.

Authors:  R M Kostrzewa; J P Kostrzewa; R A Kostrzewa; P Nowak; R Brus
Journal:  J Neural Transm (Vienna)       Date:  2007-11-12       Impact factor: 3.575

8.  5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine.

Authors:  M I Colado; T K Murray; A R Green
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

9.  Neurochemical and neuropharmacological properties of 4-fluorotranylcypromine.

Authors:  R T Coutts; T S Rao; G B Baker; R G Micetich; T W Hall
Journal:  Cell Mol Neurobiol       Date:  1987-09       Impact factor: 5.046

10.  Mesolimbic dopamine neurons: effects of 6-hydroxydopamine-induced destruction and receptor blockade on drug-induced rotation of rats.

Authors:  P H Kelly; K E Moore
Journal:  Psychopharmacology (Berl)       Date:  1977-11-24       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.